These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10599510)

  • 1. [Troponin component of the cardiotropic effect of levosimendan on the isolated myocardium from patients with chronic coronary insufficiency].
    Afanas'ev SA; Timofeev VIu; Karpov RS
    Biull Eksp Biol Med; 1999 Oct; 128(10):457-8. PubMed ID: 10599510
    [No Abstract]   [Full Text] [Related]  

  • 2. [The characteristics of the inotropic effects of Levosimendan on the isolated myocardium of patients with ischemic heart disease].
    Afanas'ev SA; Timofeev VIu
    Eksp Klin Farmakol; 2000; 63(2):35-8. PubMed ID: 10834091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of levosimendan on myocardial function in ropivacaine toxicity in isolated guinea pig heart preparations.
    Stehr SN; Christ T; Rasche B; Rasche S; Wettwer E; Deussen A; Ravens U; Koch T; Hübler M
    Anesth Analg; 2007 Sep; 105(3):641-7. PubMed ID: 17717217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct myocardial effects of levosimendan in humans with left ventricular dysfunction: alteration of force-frequency and relaxation-frequency relationships.
    Givertz MM; Andreou C; Conrad CH; Colucci WS
    Circulation; 2007 Mar; 115(10):1218-24. PubMed ID: 17339544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct cardiac effects of dobutamine, dopamine, epinephrine, and levosimendan in isolated septic rat hearts.
    Zausig YA; Geilfus D; Missler G; Sinner B; Graf BM; Zink W
    Shock; 2010 Sep; 34(3):269-74. PubMed ID: 19997056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Calcium sensitizers--a new group of drugs that increase myocardium contractility].
    Laine M; Lehtonen L; Nieminen MS
    Duodecim; 2000; 116(20):2181-3. PubMed ID: 12017622
    [No Abstract]   [Full Text] [Related]  

  • 7. Inotropic, vasodilating and preconditioning actions of levosimendan in the heart.
    Meyer K; Schipke JD; Klocke RC; Gams E; Korbmacher B
    Thorac Cardiovasc Surg; 2008 Oct; 56(7):379-85. PubMed ID: 18810693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cardiotonic effects of levosimendan in guinea pig hearts are modulated by beta-adrenergic stimulation.
    Bódi A; Szilágyi S; Edes I; Papp Z
    Gen Physiol Biophys; 2003 Sep; 22(3):313-27. PubMed ID: 14986883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preconditioning with levosimendan prevents contractile dysfunction due to H2O2-induced oxidative stress in human myocardium.
    Sahin AS; Görmüş N; Duman A
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):419-23. PubMed ID: 18049310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ca2+ sensitizer superior to catecholamine during myocardial stunning?
    Meyer K; Klocke RC; Schipke JD; Gams E; Korbmacher B
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):326-31. PubMed ID: 18539040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial efficiency during calcium sensitization with levosimendan: a noninvasive study with positron emission tomography and echocardiography in healthy volunteers.
    Ukkonen H; Saraste M; Akkila J; Knuuti MJ; Lehikoinen P; Någren K; Lehtonen L; Voipio-Pulkki LM
    Clin Pharmacol Ther; 1997 May; 61(5):596-607. PubMed ID: 9164421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calcium sensitizer agents in heart failure therapy].
    Iwama Y; Takagi A
    Nihon Rinsho; 2007 May; 65 Suppl 5():61-5. PubMed ID: 17571366
    [No Abstract]   [Full Text] [Related]  

  • 13. What is the in vivo mechanism of action of levosimendan?
    MacGowan GA
    J Card Fail; 2005 Aug; 11(6):482; author reply 482-3. PubMed ID: 16105641
    [No Abstract]   [Full Text] [Related]  

  • 14. Levosimendan in regional myocardial ischemia.
    Pieske B
    Cardiovasc Drugs Ther; 2002 Sep; 16(5):379-81. PubMed ID: 12656119
    [No Abstract]   [Full Text] [Related]  

  • 15. [Contribution of alpha-adrenoceptors to the contractility of the human myocardium in chronic coronary insufficiency].
    Afanas'ev SA; Ugdyzhekova DS; Karpov RS
    Fiziol Cheloveka; 2005; 31(1):133-6. PubMed ID: 15835771
    [No Abstract]   [Full Text] [Related]  

  • 16. Early and sustained haemodynamic improvement with levosimendan compared to intraaortic balloon counterpulsation (IABP) in cardiogenic shock complicating acute myocardial infarction.
    Christoph A; Prondzinsky R; Russ M; Janusch M; Schlitt A; Lemm H; Reith S; Werdan K; Buerke M
    Acute Card Care; 2008; 10(1):49-57. PubMed ID: 17924229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia.
    Sonntag S; Sundberg S; Lehtonen LA; Kleber FX
    J Am Coll Cardiol; 2004 Jun; 43(12):2177-82. PubMed ID: 15193677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based use of levosimendan in different clinical settings.
    De Luca L; Colucci WS; Nieminen MS; Massie BM; Gheorghiade M
    Eur Heart J; 2006 Aug; 27(16):1908-20. PubMed ID: 16682381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [If the myofilaments become sensitive: Ca2+-sensitizer for the therapy of heart insufficiency].
    Schwinger RH; Brixius K
    Dtsch Med Wochenschr; 2005 Apr; 130(15):969-73. PubMed ID: 15812725
    [No Abstract]   [Full Text] [Related]  

  • 20. [PHARMACOLOGICAL CARDIOPROTECTION DURING REPERFUSION OF ISOLATED HEART].
    Grigor'ev EV; Toropova YG; Plotnikov GP; Krutitskiy SS; Shukevich DL; Salmin VV; Golovkin AS
    Anesteziol Reanimatol; 2015; 60(2):12-6. PubMed ID: 26148355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.